Welcome to our dedicated page for Biophytis SA American Depositary Share (0.01 Euro) news (Ticker: BPTS), a resource for investors and traders seeking the latest updates and insights on Biophytis SA American Depositary Share (0.01 Euro) stock.
Biophytis S.A. reports clinical-stage biotechnology developments centered on treatments for age-related diseases. Recurring updates focus on BIO101 (20-hydroxyecdysone), the company’s lead small-molecule drug candidate, across obesity, sarcopenia, Duchenne muscular dystrophy, and respiratory indications including severe forms of Covid-19.
Company news also covers regulatory submissions and authorizations for clinical studies, presentations of trial results, manufacturing scale-up for GMP-compliant supply, licensing and partnership activity in Latin America and Asia, and periodic financial results. The issuer’s American depositary security reflects parent-company announcements from Biophytis S.A. and its public-company disclosures.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.